Company intelligence / Profile preview

Allegro Diagnostics

Boston, Massachusetts, United Statesselling.com ↗

Ownership: Private
Development stage: Other

Overview

Developed and commercialized genomic tests to support the diagnosis and management of lung cancer, including a genetic test that diagnoses cancer in smokers/ex-smokers without requiring invasive biopsy. The company was acquired by Veracyte in September 2014 to accelerate Veracyte’s entry into the lung cancer diagnostics market

Therapeutic areas: PulmonologyOncology
Modalities: Diagnostic test (genomic test)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Allegro Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allegro Diagnostics.

Explore the full profile